Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hepatic Encephalopathy (HE) Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hepatic Encephalopathy (HE) Therapeuticsmarket, defines the market attractiveness level of Hepatic Encephalopathy (HE) Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hepatic Encephalopathy (HE) Therapeutics industry, describes the types of Hepatic Encephalopathy (HE) Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hepatic Encephalopathy (HE) Therapeutics market and the development prospects and opportunities of Hepatic Encephalopathy (HE) Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hepatic Encephalopathy (HE) Therapeutics market in Chapter 13.
By Player:
ASKA Pharmaceutical
COSMO PHARMACEUTICALS
Valeant
Mallinckrodt
By Type:
Lactulose
Rifaximin
Neomycin
Probiotics
Thiamine
By End-User:
Acute Liver Failure
Portal Systemic Bypass Without Liver Disease
Liver Cirrhosis
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hepatic Encephalopathy (HE) Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hepatic Encephalopathy (HE) Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hepatic Encephalopathy (HE) Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hepatic Encephalopathy (HE) Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hepatic Encephalopathy (HE) Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Hepatic Encephalopathy (HE) Therapeutics Consumption (2017-2022)
-
7.2 United States Hepatic Encephalopathy (HE) Therapeutics Consumption (2017-2022)
-
7.3 Europe Hepatic Encephalopathy (HE) Therapeutics Consumption (2017-2022)
-
7.4 China Hepatic Encephalopathy (HE) Therapeutics Consumption (2017-2022)
-
7.5 Japan Hepatic Encephalopathy (HE) Therapeutics Consumption (2017-2022)
-
7.6 India Hepatic Encephalopathy (HE) Therapeutics Consumption (2017-2022)
-
7.7 South Korea Hepatic Encephalopathy (HE) Therapeutics Consumption (2017-2022)
8 Region and Country-wise Hepatic Encephalopathy (HE) Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Hepatic Encephalopathy (HE) Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Hepatic Encephalopathy (HE) Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Hepatic Encephalopathy (HE) Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Hepatic Encephalopathy (HE) Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Hepatic Encephalopathy (HE) Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Hepatic Encephalopathy (HE) Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Hepatic Encephalopathy (HE) Therapeutics Consumption Forecast (2022-2028)
9 Global Hepatic Encephalopathy (HE) Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Hepatic Encephalopathy (HE) Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Lactulose Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Rifaximin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Neomycin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Probiotics Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Thiamine Consumption and Growth Rate (2017-2022)
-
9.2 Global Hepatic Encephalopathy (HE) Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Acute Liver Failure Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Portal Systemic Bypass Without Liver Disease Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Liver Cirrhosis Consumption and Growth Rate (2017-2022)
10 Global Hepatic Encephalopathy (HE) Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Hepatic Encephalopathy (HE) Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Lactulose Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Rifaximin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Neomycin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Probiotics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Thiamine Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hepatic Encephalopathy (HE) Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Acute Liver Failure Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Portal Systemic Bypass Without Liver Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Liver Cirrhosis Consumption Forecast and Growth Rate (2022-2028)
11 Global Hepatic Encephalopathy (HE) Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hepatic Encephalopathy (HE) Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hepatic Encephalopathy (HE) Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hepatic Encephalopathy (HE) Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hepatic Encephalopathy (HE) Therapeutics Market Competitive Analysis
-
14.1 ASKA Pharmaceutical
-
14.1.1 ASKA Pharmaceutical Company Details
-
14.1.2 ASKA Pharmaceutical Hepatic Encephalopathy (HE) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 ASKA Pharmaceutical Hepatic Encephalopathy (HE) Therapeutics Product and Service
-
14.2 COSMO PHARMACEUTICALS
-
14.2.1 COSMO PHARMACEUTICALS Company Details
-
14.2.2 COSMO PHARMACEUTICALS Hepatic Encephalopathy (HE) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 COSMO PHARMACEUTICALS Hepatic Encephalopathy (HE) Therapeutics Product and Service
-
14.3 Valeant
-
14.3.1 Valeant Company Details
-
14.3.2 Valeant Hepatic Encephalopathy (HE) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Valeant Hepatic Encephalopathy (HE) Therapeutics Product and Service
-
14.4 Mallinckrodt
-
14.4.1 Mallinckrodt Company Details
-
14.4.2 Mallinckrodt Hepatic Encephalopathy (HE) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Mallinckrodt Hepatic Encephalopathy (HE) Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hepatic Encephalopathy (HE) Therapeutics
-
Figure Hepatic Encephalopathy (HE) Therapeutics Picture
-
Table Global Hepatic Encephalopathy (HE) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hepatic Encephalopathy (HE) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hepatic Encephalopathy (HE) Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hepatic Encephalopathy (HE) Therapeutics Consumption by Country (2017-2022)
-
Figure United States Hepatic Encephalopathy (HE) Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Hepatic Encephalopathy (HE) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Hepatic Encephalopathy (HE) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Hepatic Encephalopathy (HE) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Hepatic Encephalopathy (HE) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hepatic Encephalopathy (HE) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatic Encephalopathy (HE) Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Hepatic Encephalopathy (HE) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hepatic Encephalopathy (HE) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hepatic Encephalopathy (HE) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hepatic Encephalopathy (HE) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hepatic Encephalopathy (HE) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hepatic Encephalopathy (HE) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lactulose Consumption and Growth Rate (2017-2022)
-
Figure Global Rifaximin Consumption and Growth Rate (2017-2022)
-
Figure Global Neomycin Consumption and Growth Rate (2017-2022)
-
Figure Global Probiotics Consumption and Growth Rate (2017-2022)
-
Figure Global Thiamine Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Liver Failure Consumption and Growth Rate (2017-2022)
-
Figure Global Portal Systemic Bypass Without Liver Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Cirrhosis Consumption and Growth Rate (2017-2022)
-
Figure Global Lactulose Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rifaximin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neomycin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Probiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Thiamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acute Liver Failure Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Portal Systemic Bypass Without Liver Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liver Cirrhosis Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hepatic Encephalopathy (HE) Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hepatic Encephalopathy (HE) Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table ASKA Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table ASKA Pharmaceutical Hepatic Encephalopathy (HE) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table ASKA Pharmaceutical Hepatic Encephalopathy (HE) Therapeutics Product and Service
-
Table COSMO PHARMACEUTICALS (Foundation Year, Company Profile and etc.)
-
Table COSMO PHARMACEUTICALS Hepatic Encephalopathy (HE) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table COSMO PHARMACEUTICALS Hepatic Encephalopathy (HE) Therapeutics Product and Service
-
Table Valeant (Foundation Year, Company Profile and etc.)
-
Table Valeant Hepatic Encephalopathy (HE) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Hepatic Encephalopathy (HE) Therapeutics Product and Service
-
Table Mallinckrodt (Foundation Year, Company Profile and etc.)
-
Table Mallinckrodt Hepatic Encephalopathy (HE) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mallinckrodt Hepatic Encephalopathy (HE) Therapeutics Product and Service
-
